Condition
Antipsychotics and Neuroleptics Toxicity
Total Trials
5
Recruiting
0
Active
2
Completed
2
Success Rate
100.0%+14% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Active Not Recruiting2
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06357195Active Not Recruiting
DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients
NCT05033119Active Not Recruiting
PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics
NCT06200584Not ApplicableCompletedPrimary
Synergistic Effect of Vitamin E & D in Reducing Risk of Effects Associated With Atypical Anti-psychotics
NCT04668248Not ApplicableCompleted
Novel Application of Simulation for Providers to Overcome Decisional Gaps in High-risk Prescribing
NCT04575103Not ApplicableUnknown
Monitoring of Arrhythmias in Patients Treated With Antipsychotics
Showing all 5 trials